GWM
ARAV

Geneos Wealth Management’s Aravive, Inc. Common Stock ARAV Stock Holding History

Geneos Wealth Management’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,810
Closed -$24K – 2837
2022
Q1 		$24K Hold
12,810
– – ﹤0.01% 1728
2021
Q4 		$28K Hold
12,810
– – ﹤0.01% 1723
2021
Q3 		$47K Buy
12,810
+7,200
+128% +$30.7K ﹤0.01% 1530
2021
Q2 		$32K Hold
5,610
– – ﹤0.01% 1694
2021
Q1 		$29K Buy
+5,610
New +$36.9K ﹤0.01% 1898

Other funds holding ARAV

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geneos Wealth Management's ARAV Position: Q2 2022 in Review

Geneos Wealth Management sold out of Aravive, Inc. Common Stock (ARAV) in Q2 2022, closing a stake of 12,810 shares — an estimated $24K sold.

Geneos Wealth Management first reported a position in ARAV in Q1 2021 and held it in 5 quarters. The position peaked at $47K in Q3 2021. 36 funds tracked by Wall St. Rank hold ARAV as of Q2 2022.

  • Geneos Wealth Management reported no remaining Aravive, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 12,810 Aravive, Inc. Common Stock shares in Q2 2022, an estimated $24K.
  • Geneos Wealth Management first reported a position in Aravive, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Geneos Wealth Management's Aravive, Inc. Common Stock position peaked at $47K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q2 2022.

Based on Geneos Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.